At the time of writing, Cabaletta Bio Inc [CABA] stock is trading at $2.49, up 6.41%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The CABA shares have gain 8.73% over the last week, with a monthly amount glided 8.73%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Cabaletta Bio Inc [NASDAQ: CABA] stock has seen the most recent analyst activity on December 20, 2024, when Evercore ISI downgraded its rating to a In-line and also revised its price target to $6 from $15. Previously, Wells Fargo downgraded its rating to Equal Weight on December 19, 2024, and dropped its price target to $6. On October 10, 2024, UBS initiated with a Buy rating and assigned a price target of $10 on the stock. Jefferies started tracking the stock assigning a Buy rating and suggested a price target of $36 on February 05, 2024. William Blair initiated its recommendation with a Outperform and recommended $38 as its price target on November 29, 2023. Cantor Fitzgerald started tracking with a Overweight rating for this stock on October 24, 2023, and assigned it a price target of $40. In a note dated October 19, 2023, Stifel initiated an Buy rating and provided a target price of $31 on this stock.
For the past year, the stock price of Cabaletta Bio Inc fluctuated between $1.76 and $26.35. Currently, Wall Street analysts expect the stock to reach $16.33 within the next 12 months. Cabaletta Bio Inc [NASDAQ: CABA] shares were valued at $2.49 at the most recent close of the market. An investor can expect a potential return of 555.82% based on the average CABA price forecast.
Analyzing the CABA fundamentals
Gross Profit Margin for this corporation currently stands at 0.71% with Operating Profit Margin at -28.55%, Pretax Profit Margin comes in at -25.98%, and Net Profit Margin reading is -25.98%. To continue investigating profitability, this company’s Return on Assets is posted at -0.51, Equity is -0.5 and Total Capital is -0.63.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.32 points at the first support level, and at 2.15 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.58, and for the 2nd resistance point, it is at 2.67.
Ratios To Look Out For
It is important to note that Cabaletta Bio Inc [NASDAQ:CABA] has a current ratio of 8.11. As well, the Quick Ratio is 8.11, while the Cash Ratio is 7.46.
Transactions by insiders
Recent insider trading involved Binder Gwendolyn, that happened on Jan 19 ’24 when 11000.0 shares were sold.
